John Moore - STANLEY ELECTRIC Independent Director
| STAA Stock | EUR 24.60 0.00 0.00% |
Director
Mr. John C. Moore serves as Independent Director of the Company. From December 2012 through December 2016, Mr. Moore served as a director and Chairperson of the Board of Directors of Optovue, Inc., an ophthalmic medical device company. Since May 2014 Mr. Moore has served as Chief Technical Officer of TearSolutions, L.L.C., an ophthalmic pharmaceutical company. Between April 2005 and January 2007, Mr. Moore served as Chief Executive Officer of Notal Vision, an Israelbased ophthalmic company that develops diagnostic solutions for the early detection and monitoring of agerelated macular degeneration . Mr. Moore served as the President and Chief Executive Officer of Laser Diagnostic Technologies, a manufacturer of ophthalmic diagnostic laser devices used for the early detection of glaucoma, from 2000 until 2004 when it was acquired by Carl Zeiss Meditec, Inc. Before this, Mr. Moore was a vice president at Alcon Laboratories, one of the largest companies in the ophthalmic surgical sector, where he was responsible for pursuing and executing strategic acquisitions and partnerships to broaden that companys product portfolio. Mr. Moore also spent more than 10 years in various leadership roles at Carl Zeiss, Inc., a multinational ophthalmic company with primary businesses in optics, medical, scientific and semiconductor products since 2008.
| Age | 75 |
| Tenure | 16 years |
John Moore Latest Insider Activity
Tracking and analyzing the buying and selling activities of John Moore against STANLEY ELECTRIC stock is an integral part of due diligence when investing in STANLEY ELECTRIC. John Moore insider activity provides valuable insight into whether STANLEY ELECTRIC is net buyers or sellers over its current business cycle. Note, STANLEY ELECTRIC insiders must abide by specific rules, including filing SEC forms every time they buy or sell STANLEY ELECTRIC'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
John Moore over two months ago Disposition of 20922 shares by John Moore of Edgewise Therapeutics at 27.6295 subject to Rule 16b-3 | ||
John Moore over two months ago Acquisition by John Moore of 23125 shares of Edgewise Therapeutics subject to Rule 16b-3 | ||
John Moore over six months ago Disposition of 9232 shares by John Moore of Edgewise Therapeutics at 9.3069 subject to Rule 16b-3 | ||
John Moore over six months ago Disposition of 17993 shares by John Moore of Edgewise Therapeutics at 1.93 subject to Rule 16b-3 |
STANLEY ELECTRIC Leadership Team
Elected by the shareholders, the STANLEY ELECTRIC's board of directors comprises two types of representatives: STANLEY ELECTRIC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of STANLEY. The board's role is to monitor STANLEY ELECTRIC's management team and ensure that shareholders' interests are well served. STANLEY ELECTRIC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, STANLEY ELECTRIC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| HansMartin Blickensdoerfer, Senior Vice President - Commercial Operations, Direct Markets Europe and China | ||
| Gilbert Kliman, Director | ||
| Thomas Frinzi, Director | ||
| Samuel Gesten, Vice President General Counsel, Corporate Compliance Officer and Secretary | ||
| Deborah Andrews, Chief Accounting Officer, Vice President | ||
| Elizabeth Yeu, Director | ||
| Caren Mason, President, Chief Executive Officer, Director | ||
| Scott Barnes, Chief Medical Officer | ||
| Patrick Williams, Chief Financial Officer | ||
| Louis Silverman, Independent Chairman of the Board | ||
| James Francese, Senior Vice President - Commercial Operations, North American and APAC | ||
| John Moore, Independent Director | ||
| Jon Hayashida, Vice President of Global Clinical and Medical Affairs | ||
| Keith Holliday, Vice President - Research & Development | ||
| K Yu, Director | ||
| Graydon Hansen, Chief Manufacturing Officer and Senior Vice President, Global Operations | ||
| Stephen Farrell, Independent Director |
STANLEY Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is STANLEY ELECTRIC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Current Valuation | 1.94 B | |||
| Price To Book | 1.42 X | |||
| Price To Sales | 1.52 X | |||
| Revenue | 382.56 B | |||
| EBITDA | 72.18 B | |||
| Net Income | 21.45 B | |||
| Total Debt | 10 B | |||
| Cash Flow From Operations | 36.88 B | |||
| Number Of Employees | 32 | |||
| Market Capitalization | 3.79 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in STANLEY Stock
STANLEY ELECTRIC financial ratios help investors to determine whether STANLEY Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in STANLEY with respect to the benefits of owning STANLEY ELECTRIC security.